Relating to innovation waivers for certain insurance laws, regulations, and requirements; authorizing a fee; creating an administrative penalty.
HB 4457 would create a new Chapter 87 in the Texas Insurance Code establishing a “regulatory sandbox” for insurance innovation. Under the bill, the insurance commissioner could grant temporary waivers or variances from certain insurance laws, rules, or requirements when doing so would allow the introduction of an innovative or more efficient insurance product or service, so long as consumer risk is not substantially increased, the public policy goals of the underlying law are met by other means, and the waiver is in the public interest.
The bill sets out an application process, public notice requirements, limits on waiver duration, consumer disclosures, financial security requirements, reporting obligations, and rules for revocation. It also caps participation at 10,000 consumers per waiver, allows a one-time extension of up to 12 months, and authorizes the commissioner to impose terms and limitations. The commissioner would be required to report annually to state leaders on waiver activity and recommendations for statutory changes, and could enter into reciprocity agreements with other states with similar laws.
HB 4457 would give the Texas Department of Insurance new authority to temporarily suspend or modify certain insurance regulatory requirements for approved innovation projects, while preserving limits on solvency rules, taxes and fees, trade practices, accreditation-related requirements, and other excluded provisions. It would add new administrative procedures, create a fee set by the commissioner, and establish a new administrative penalty of up to $1,000 for noncompliance with waiver terms or chapter requirements. The bill would affect insurers, insurtech firms, and other regulated persons seeking to test new products or services in Texas.
The available context shows the bill was referred to the House Insurance Committee and there are no recorded committee transcripts or votes in the provided material, so there is no documented public debate or recorded partisan split here. Based on the bill text, the measure appears designed to encourage innovation while retaining consumer protections, suggesting a generally pro-innovation regulatory approach. The structure of the bill also indicates an effort to balance flexibility with oversight through notice, reporting, monitoring, and revocation provisions.
The main policy tension in the bill is between regulatory flexibility and consumer protection. Supporters would likely favor the ability to test new insurance technologies and products without being blocked by existing rules, while opponents or cautious stakeholders may worry that waivers could weaken protections, create uneven treatment among market participants, or expose consumers to risk. Specific points that may draw scrutiny include the commissioner’s broad discretion to grant waivers, the exclusion of contested-case procedures for waiver decisions, the ability to impose fees and penalties, and whether the 10,000-consumer cap and disclosure requirements are sufficient safeguards.